Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer
NCT05669586
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Organoid
Interventions
DRUG:
Antitumor therapy guided by organoid drug sensitivity test
Sponsor
Affiliated Hospital of Jiangnan University